Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Analytical Tool - Cancer Therapeutic Antibodies -' returned 110 results - Page 1 of 6  FEATURED RESULTS Drug Delivery in Cancer - Technologies, Markets and Companies Antibody Drug Target Atlas in Oncology Cancer Diagnostic Testing World Markets Cancer and its Management, 6th Edition Outcome Prediction in Cancer   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Analytical Tool - Cancer Therapeutic Antibodies   Bioseeker, Sep 2011 "Analytical Tool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment Analytical Tool - The Commercial Success of Cancer Therapeutic Antibodies   Bioseeker, June 2006 "Analytical Tool - The Commercial Success of Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody R Triple Analysis: Breast Cancer, Cancer Vaccines and Antibodies   Bioseeker, Sep 2011, Pages: 3516 publication: Portfolio Analytics and Planning in the Breast Cancer Pipeline - Change is Around the Corner in a Highly Competitive Market Place Part II: Cancer Vaccines The cancer vaccine report part comprises Triple Analysis: Pancreatic Cancer, Cancer Vaccines and Antibodies   Bioseeker, Sep 2011, Pages: 3213 Tool for Optimizing the Pipeline Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development strategies for 531 antibody drugs in oncology within the portfolio Triple Analysis: Lung Cancer, Cancer Vaccines and Antibodies   Bioseeker, Sep 2011, Pages: 3926 is based on the following publication: Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Part II: Cancer Vaccines The cancer vaccine report part comprises defined Triple Analysis: Breast Cancer, Lung Cancer and Antibodies   Bioseeker, Sep 2011, Pages: 4180 This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lung Cancer and by the compound strategy of Antibodies. Each of these three individual parts is evaluated Triple Analysis: Prostate Cancer, Cancer Vaccines and Antibodies   Bioseeker, Sep 2011, Pages: 3441 on the following publication: A Decision Support Tool for Optimizing the Prostate Cancer Pipeline: From Research and Development to Market Part II: Cancer Vaccines The cancer vaccine report part comprises defined Triple Analysis: Lung Cancer, Pancreatic Cancer and Antibodies   Bioseeker, Sep 2011, Pages: 3877 This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the compound strategy of Antibodies. Each of these three individual parts Triple Analysis: Colorectal Cancer, Cancer Vaccines and Antibodies   Bioseeker, Sep 2011, Pages: 3659 Tool for Optimizing the Pipeline Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development strategies for 531 antibody drugs in oncology within the portfolio Triple Analysis: Breast Cancer, Prostate Cancer and Antibodies   Bioseeker, Sep 2011, Pages: 3695 This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Prostate Cancer and by the compound strategy of Antibodies. Each of these three individual parts Triple Analysis: Breast Cancer, Colorectal Cancer and Antibodies   Bioseeker, Sep 2011, Pages: 3913 This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Colorectal Cancer and by the compound strategy of Antibodies. Each of these three individual parts Triple Analysis: Pancreatic Cancer, Prostate Cancer and Antibodies   Bioseeker, Sep 2011, Pages: 3392 This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the compound strategy of Antibodies. Each of these three individual parts Triple Analysis: Lung Cancer, Prostate Cancer and Antibodies   Bioseeker, Sep 2011, Pages: 4105 This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the compound strategy of Antibodies. Each of these three individual parts Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Antibodies   Bioseeker, Sep 2011, Pages: 3610 This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Pancreatic Cancer and by the compound strategy of Antibodies. Each of these three individual parts Triple Analysis: Colorectal Cancer, Lung Cancer and Antibodies   Bioseeker, Sep 2011, Pages: 4323 This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Lung Cancer and by the compound strategy of Antibodies. Each of these three individual parts Triple Analysis: Colorectal Cancer, Prostate Cancer and Antibodies   Bioseeker, Sep 2011, Pages: 3838 This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Prostate Cancer and by the compound strategy of Antibodies. Each of these three individual parts The Global Competitive Landscape of Antibody Drug Development in Cancer: The Faster Route to Consider Your Options and Position of Others   Bioseeker, Sep 2011, Pages: 1944 in the Cancer Gene Census and in the Catalogue of Somatic Mutations in Cancer 6.4 Antibody Therapeutics is Stimulated by Available Structure Data on Biological Targets 6.5 Target-Target Interactions among Triple Analysis: Lung Cancer, Protein Kinase Inhibitors and Antibodies   Bioseeker, Sep 2011, Pages: 4709 : Protein Kinase Therapeutics in Oncology - Where to Commercialize? Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development strategies for 531 antibody drugs Triple Analysis: Cancer Vaccines, Protein Kinase Inhibitors and Antibodies   Bioseeker, Sep 2011, Pages: 4045 : Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline Part II: Protein Kinase Inhibitors The protein kinase report comprises defined and up to date development strategies for 409 Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Antibodies   Bioseeker, Sep 2011, Pages: 4224 Therapeutics in Oncology - Where to Commercialize? Part III: Antibodies The cancer antibody drug report part comprises defined and up to date development strategies for 531 antibody drugs in oncology within Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network